Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292


SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca : The latest news on COVID-19 developments in Canada

05/12/2021 | 01:50pm EDT

The latest news on COVID-19 developments in Canada (all times Eastern):

1:45 p.m.

Yukon's health minister says the territory will be vaccinating all youth 12 years and older with the Pfizer-BioNTech vaccine.

Tracy-Anne McPhee says the territory has reached a deal with the federal government to get enough doses to fully vaccinate all 2,641 youth.

McPhee says the goal is to give a first dose by the end of the school year and fully vaccinate youths by mid-July.

Yukon has one active case of COVID-19.


1:30 p.m.

Manitoba is reporting 364 new COVID-19 cases and three deaths.

That brings the total deaths to date to 1,000.

The five-day average test positivity rate remains high at 12.1 per cent provincially and 14.4 per cent in Winnipeg.


1:30 p.m.

Newfoundland and Labrador is moving communities in the western part of the province into alert level 4 at midnight.

Chief medical officer of health Dr. Janice Fitzgerald says there are three known COVID-19 cases linked to a school in the Codroy Valley area.

She says communities from South Branch to Port aux Basques will move to alert level 4, under which gyms and restaurant dining rooms are closed and gatherings limited.

Health officials in the province are reporting 10 new COVID-19 cases today.

The province has 81 active reported infections and one person in hospital with the disease.


1 p.m.

Manitoba has opened COVID-19 vaccination appointments to everyone aged 18 and up.

Health officials say supplies have been increasing steadily and everyone aged 12 and up should get a first dose in the first half of June.

Manitoba is also adjusting its plan to distribute Oxford-AstraZeneca vaccines.

First doses at medical clinics and pharmacies will now only be given to people who might not otherwise be immunized at other sites.

Most will be held for second doses of people who received an AstraZeneca shot in the first go-around.


12:25 p.m.

New Brunswick is reporting nine new cases of COVID-19 today, including two travel-related cases involving New Brunswickers isolating outside the province.

New Brunswick has 123 active reported cases of COVID-19.

Seven patients are in hospital with the disease in the province, including three in intensive care.

Four New Brunswickers are hospitalized with COVID-19 out of province.


12 p.m.

Ontario expects to receive more than 254,000 doses of the Oxford-AstraZeneca COVID-19 vaccine next week and will be reserving them for second shots.

It's still determining, however, when it will start administering those second doses.

The province announced a pause yesterday on using AstraZeneca for first shots due to an increased risk of a rare blood-clotting syndrome linked to the vaccine.

There have been at least eight cases in Ontario of the rare blood clotting syndrome linked to the AstraZeneca shot out of more than 901,800 doses given in the province.

None of the Ontario cases have been fatal.

The province also says it is developing a plan to vaccinate children aged 12 to 17 starting in June.


11:20 a.m.

Quebec is reporting 745 new cases of COVID-19 today and 11 more deaths attributed to the novel coronavirus, including three within the past 24 hours.

Health officials say hospitalizations dropped by 10, to 530, and 126 people were in intensive care, a drop of two.

The province says 72,946 doses of a COVID-19 vaccine were administered Tuesday; about 44 per cent of Quebecers have received at least one dose.

Quebec has reported a total of 360,201 cases of COVID-19 and 11,012 deaths linked to the virus.


10:30 a.m.

Ontario is counting 2,320 new COVID-19 diagnoses, and 32 added deaths.

The province says the positive cases come from nearly 45,700 tests.

It says 1,673 COVID-19 patients are in hospital, including 776 in ICU.


10 a.m.

Nunavut is reporting eight new cases of COVID-19 today, bringing the territory's active case count to 69.

All active cases are in Iqaluit, where an outbreak has been ongoing since the city's first case was declared April 14.

Iqaluit remains under a strict lockdown with all schools, non-essential businesses and workplaces closed.

Travel is also restricted out of Iqaluit to other Nunavut communities.


This report by The Canadian Press was first published May 12, 2021.

© 2021 The Canadian Press. All rights reserved., source Canadian Press DataFile

All news about ASTRAZENECA PLC
05:07pCureVac fails in pivotal COVID-19 vaccine trial with 47% efficacy
04:57pASTRAZENECA  : JPMorgan, Goldman Sachs delay workers' return to U.K. offices
11:06aASTRAZENECA  : Second Phase of Covid-19 Vaccinations Begins
09:22aEU Says Johnson & Johnson May Not Meet Vaccine Supply Commitment After Jabs C..
07:49aUK Vaccination Rate Slows Down On Shortage Of Pfizer Jabs
04:08aER+/ HER2-VE BREAST CANCER PIPELINE : Emerging Therapies and Key pharma players ..
01:30aASTRAZENECA  : COVID-19 Approved In Pakistan For People Under 40
06/15US, EU Vow to Provide COVID-19 Vaccine to Two-Thirds of World's Population by..
06/15INDIAN SCIENTISTS : We didn't back doubling of vaccine dosing gap
06/15European Stocks End Higher as Investors Wait for Fed
More news
Financials (USD)
Sales 2021 30 989 M - -
Net income 2021 4 562 M - -
Net Debt 2021 10 731 M - -
P/E ratio 2021 24,2x
Yield 2021 3,39%
Capitalization 110 B 156 B -
EV / Sales 2021 3,91x
EV / Sales 2022 3,41x
Nbr of Employees 76 100
Free-Float 95,7%
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 132,31 $
Last Close Price 84,04 $
Spread / Highest target 103%
Spread / Average Target 57,4%
Spread / Lowest Target 14,5%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Marc Pierre Jean Dunoyer Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas N. Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
ASTRAZENECA PLC13.91%154 316
JOHNSON & JOHNSON4.52%433 167
ROCHE HOLDING AG11.21%330 710
PFIZER, INC.7.55%221 613
NOVARTIS AG0.77%210 689
ABBVIE INC.8.10%204 582